CY1106988T1 - Ημισυνθετικeς εκτεϊνασκιδινες - Google Patents
Ημισυνθετικeς εκτεϊνασκιδινεςInfo
- Publication number
- CY1106988T1 CY1106988T1 CY20071101439T CY071101439T CY1106988T1 CY 1106988 T1 CY1106988 T1 CY 1106988T1 CY 20071101439 T CY20071101439 T CY 20071101439T CY 071101439 T CY071101439 T CY 071101439T CY 1106988 T1 CY1106988 T1 CY 1106988T1
- Authority
- CY
- Cyprus
- Prior art keywords
- semi
- synthetic
- synthetic effects
- effects
- ecteinascidine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- PKVRCIRHQMSYJX-AIFWHQITSA-N trabectedin Chemical compound C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](O)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 PKVRCIRHQMSYJX-AIFWHQITSA-N 0.000 abstract 1
- 229960000977 trabectedin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8080298P | 1998-04-06 | 1998-04-06 | |
| EP99916379A EP1067933B1 (en) | 1998-04-06 | 1999-04-05 | Semi-synthetic ecteinascidins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106988T1 true CY1106988T1 (el) | 2012-09-26 |
Family
ID=22159716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071101439T CY1106988T1 (el) | 1998-04-06 | 2007-11-08 | Ημισυνθετικeς εκτεϊνασκιδινες |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6124293A (enExample) |
| EP (2) | EP1067933B1 (enExample) |
| JP (1) | JP4443043B2 (enExample) |
| KR (1) | KR100603219B1 (enExample) |
| CN (1) | CN1157189C (enExample) |
| AT (1) | ATE370148T1 (enExample) |
| AU (1) | AU758100B2 (enExample) |
| BG (1) | BG65088B1 (enExample) |
| BR (1) | BR9909488B1 (enExample) |
| CA (1) | CA2327468C (enExample) |
| CY (1) | CY1106988T1 (enExample) |
| CZ (1) | CZ301083B6 (enExample) |
| DE (1) | DE69936845T2 (enExample) |
| DK (1) | DK1067933T3 (enExample) |
| ES (1) | ES2292237T3 (enExample) |
| HU (1) | HUP0104273A3 (enExample) |
| IL (2) | IL138856A0 (enExample) |
| MX (1) | MXPA00009840A (enExample) |
| NO (1) | NO328147B1 (enExample) |
| NZ (1) | NZ507350A (enExample) |
| PL (1) | PL196809B1 (enExample) |
| PT (1) | PT1067933E (enExample) |
| RU (1) | RU2217432C2 (enExample) |
| SK (1) | SK285669B6 (enExample) |
| TR (1) | TR200002921T2 (enExample) |
| UA (1) | UA59439C2 (enExample) |
| WO (1) | WO1999051238A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985876A (en) * | 1997-04-15 | 1999-11-16 | Univ Illinois | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| IL139607A0 (en) * | 1998-05-11 | 2002-02-10 | Pharma Mar Sa | Metabolites of ecteinascidin 743 |
| MY164077A (en) * | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
| MY130271A (en) * | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
| EP1254140A4 (en) | 2000-01-19 | 2003-03-12 | Univ Columbia | SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USAGE AND SYNTHESIS THEREOF |
| US7919493B2 (en) * | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
| MXPA02011319A (es) | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
| JP2004529074A (ja) | 2000-11-03 | 2004-09-24 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | サフラマイシン、そのアナログ、およびその使用 |
| WO2002036135A2 (en) * | 2000-11-06 | 2002-05-10 | Pharma Mar, S.A. | Compositions for antitumour treatment containing ecteinascidin 743 |
| GB0117402D0 (en) | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
| GB0119243D0 (en) | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
| GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
| GB0312407D0 (en) * | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
| GB0324201D0 (en) * | 2003-10-15 | 2003-11-19 | Pharma Mar Sau | Improved antitumoral combinations |
| JP2007511499A (ja) * | 2003-11-13 | 2007-05-10 | ファーマ・マール・エス・アー・ウー | コンビネーション |
| GB0326486D0 (en) * | 2003-11-14 | 2003-12-17 | Pharma Mar Sau | Combination treatment |
| JP2007511509A (ja) * | 2003-11-14 | 2007-05-10 | ファルマ・マール・ソシエダード・アノニマ | Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法 |
| JP2008505862A (ja) * | 2004-07-09 | 2008-02-28 | ファルマ、マール、ソシエダード、アノニマ | 予後分子マーカー |
| WO2006035244A2 (en) * | 2004-09-29 | 2006-04-06 | Pharma Mar S.A., Sociedad Unipersonal | Ecteinascidin compounds as anti -inflammatory agents |
| RS50822B (sr) * | 2004-10-26 | 2010-08-31 | Pharma Mar S.A., Sociedad Unipersonal | Pegilovani lipozomalni doksorubicin u kombinaciji sa ekteinescidinom 743 |
| KR101188691B1 (ko) | 2004-10-29 | 2012-10-09 | 파르마 마르 에스.에이. | 엑티나시딘 및 디사카라이드를 포함하는 제제 |
| GB0522082D0 (en) | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
| CN100355775C (zh) * | 2006-01-20 | 2007-12-19 | 南方医科大学 | 一种海鞘多肽及其制备方法 |
| WO2009050303A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Prognostic molecular markers for et-743 treatment |
| EP2786755A3 (en) | 2010-11-12 | 2014-10-29 | Pharma Mar S.A. | Combination therapy with an antitumor alkaloid |
| RU2738741C2 (ru) * | 2016-02-04 | 2020-12-16 | Цзянсу Хэнжуй Медицин Ко., Лтд. | Инъекционная фармацевтическая композиция, включающая трабектедин, для применения вне желудочно-кишечного тракта и способ её получения |
| LT3615544T (lt) | 2017-04-27 | 2023-05-10 | Pharma Mar S.A. | Priešnavikiniai junginiai |
| CA3158733A1 (en) | 2019-11-21 | 2021-05-27 | Pilar Calvo | Methods of treating small cell lung cancer with lurbinectedin formulations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089273A (en) * | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
| US5149804A (en) * | 1990-11-30 | 1992-09-22 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 736 and 722 |
| US5256663A (en) * | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
| TW221441B (enExample) * | 1991-01-25 | 1994-03-01 | Taiho Pharmaceutical Co Ltd | |
| US5440055A (en) * | 1993-03-12 | 1995-08-08 | Aphios Corporation | Method and apparatus for extracting taxol from source materials |
| US5478932A (en) * | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
| US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
-
1999
- 1999-04-05 BR BRPI9909488-6A patent/BR9909488B1/pt not_active IP Right Cessation
- 1999-04-05 WO PCT/US1999/007471 patent/WO1999051238A1/en not_active Ceased
- 1999-04-05 JP JP2000542009A patent/JP4443043B2/ja not_active Expired - Fee Related
- 1999-04-05 TR TR2000/02921T patent/TR200002921T2/xx unknown
- 1999-04-05 CZ CZ20003650A patent/CZ301083B6/cs not_active IP Right Cessation
- 1999-04-05 PL PL343439A patent/PL196809B1/pl not_active IP Right Cessation
- 1999-04-05 CA CA002327468A patent/CA2327468C/en not_active Expired - Fee Related
- 1999-04-05 ES ES99916379T patent/ES2292237T3/es not_active Expired - Lifetime
- 1999-04-05 MX MXPA00009840A patent/MXPA00009840A/es active IP Right Grant
- 1999-04-05 EP EP99916379A patent/EP1067933B1/en not_active Expired - Lifetime
- 1999-04-05 RU RU2000128058/04A patent/RU2217432C2/ru not_active IP Right Cessation
- 1999-04-05 EP EP07011035A patent/EP1876180A3/en not_active Withdrawn
- 1999-04-05 IL IL13885699A patent/IL138856A0/xx active IP Right Grant
- 1999-04-05 PT PT99916379T patent/PT1067933E/pt unknown
- 1999-04-05 SK SK1501-2000A patent/SK285669B6/sk not_active IP Right Cessation
- 1999-04-05 CN CNB998070769A patent/CN1157189C/zh not_active Expired - Fee Related
- 1999-04-05 AT AT99916379T patent/ATE370148T1/de not_active IP Right Cessation
- 1999-04-05 AU AU34713/99A patent/AU758100B2/en not_active Ceased
- 1999-04-05 DK DK99916379T patent/DK1067933T3/da active
- 1999-04-05 US US09/286,242 patent/US6124293A/en not_active Expired - Fee Related
- 1999-04-05 KR KR1020007011112A patent/KR100603219B1/ko not_active Expired - Fee Related
- 1999-04-05 DE DE69936845T patent/DE69936845T2/de not_active Expired - Lifetime
- 1999-04-05 NZ NZ507350A patent/NZ507350A/xx unknown
- 1999-04-05 HU HU0104273A patent/HUP0104273A3/hu unknown
- 1999-05-04 UA UA2000105674A patent/UA59439C2/uk unknown
-
2000
- 2000-10-03 NO NO20004978A patent/NO328147B1/no not_active IP Right Cessation
- 2000-10-04 IL IL138856A patent/IL138856A/en not_active IP Right Cessation
- 2000-11-02 BG BG104902A patent/BG65088B1/bg unknown
-
2007
- 2007-11-08 CY CY20071101439T patent/CY1106988T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69936845D1 (de) | Halbsynthetische ectein-ascidine | |
| EA199900598A1 (ru) | Производные 1-арил- и пиридилпиразола с пестицидными свойствами | |
| EP1431275A4 (en) | DIARYL ETHER DERIVAT, THE ADDITIONAL SALT AND IMMUNOSUP PRESSIV | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| NO943002D0 (no) | Fosfono-oksymetyletere av taxanderivater | |
| CY1110914T1 (el) | Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν | |
| EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
| ATE202776T1 (de) | Piperinderivate als neurokininantagoniste | |
| FR2757857B1 (fr) | Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques | |
| EA199800692A1 (ru) | Изолируемые смеси из семян eugenia jambolana lamarck, способы их получения, способ получения оксамата натрия, лекарственные средства для профилактики и лечения диабета и применение указанных смесей, их компонентов и оксамата натрия для получения этих лекарственных средств | |
| BG102623A (bg) | Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства | |
| TR200002932T2 (tr) | Azabisayklik 5HT1 Alıcı liganolları | |
| ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| ES2179254T3 (es) | 1-poliarilpirazoles plaguicidas. | |
| ATE244712T1 (de) | Piperazino-derivative als neurokininantagonisten | |
| ATE207076T1 (de) | Ara-c derivate | |
| FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
| ES2112670T3 (es) | Derivados de ciclodextrina y su utilizacion, particularmente en cosmetica. | |
| EA200300516A1 (ru) | Комбинация, включающая камптотецин и производные стильбена, для лечения рака | |
| EA200400661A1 (ru) | Фенилалкины | |
| FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
| PT89742A (pt) | Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas | |
| DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| CY1110737T1 (el) | Υποκατεστημενες ενωσεις 1,5-διαμινοπενταν-3-ολης | |
| EA200100107A1 (ru) | Новые 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1h-бенз[f]индолы, способ их получения и их применение в качестве лекарственных средств |